These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11025617)

  • 41. Animal models to explore mechanisms of tolerance induction to FVIII: SCID mice and SCID-FVIII-KO mice.
    Gilles JG; Vanzieleghem B; Saint-Remy JM
    Haematologica; 2000 Oct; 85(10 Suppl):103-6; discussion 106-7. PubMed ID: 11187860
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A.
    Chalmers EA; Brown SA; Keeling D; Liesner R; Richards M; Stirling D; Thomas A; Vidler V; Williams MD; Young D;
    Haemophilia; 2007 Mar; 13(2):149-55. PubMed ID: 17286767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G
    Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemophilia treatment. Factor VIII inhibitors with recombinant products: prospective clinical trials.
    Lusher JM
    Haematologica; 2000 Oct; 85(10 Suppl):2-5; discussion 5-6. PubMed ID: 11187864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.
    Astermark J
    Haemophilia; 2006 Dec; 12 Suppl 6():8-13; discussion 13-4. PubMed ID: 17123388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
    Wang W; Merchlinsky M; Inman J; Golding B
    Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates.
    Tagariello G; Zanotto D; Radossi P; Sartori R; Belvini D; Salviato R
    Am J Hematol; 2007 Jun; 82(6):460-2. PubMed ID: 17211843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risks of inhibitors from recombinant factor VIII: a quarter of a century to reach the conclusion.
    Burnouf T; Strengers PF
    J Thromb Haemost; 2016 Oct; 14(10):2073-2074. PubMed ID: 27496669
    [No Abstract]   [Full Text] [Related]  

  • 52. [Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)].
    Fukutake K; Fujimari M; Ukita M; Kitahara T
    Rinsho Ketsueki; 1973 Dec; 14(0):1393-99. PubMed ID: 4807613
    [No Abstract]   [Full Text] [Related]  

  • 53. [Substitution therapy in operations on hemophiliacs].
    Meili EO; Kaufmann L; Schneider W
    Ther Umsch; 1979 Apr; 36(4):307-10. PubMed ID: 451949
    [No Abstract]   [Full Text] [Related]  

  • 54. Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency.
    Buckner TW; Nielsen BI; Key NS; Ma A
    Haemophilia; 2015 Jan; 21(1):e77-80. PubMed ID: 25472918
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs.
    Rizza CR; Matthews JM
    Br J Haematol; 1982 Sep; 52(1):13-24. PubMed ID: 6810911
    [No Abstract]   [Full Text] [Related]  

  • 56. Idiopathic inhibitor of factor VIII and its treatment by immunosuppression.
    Ting HC; Wang F; Por P; Nurulhuda A
    Acta Haematol; 1980; 64(4):236-8. PubMed ID: 6781207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acquired haemophilia, an unusual cause of severe postpartum haemorrhage.
    Kadir RA; Koh MB; Lee CA; Pasi KJ
    Br J Obstet Gynaecol; 1997 Jul; 104(7):854-6. PubMed ID: 9236657
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Disappearance of canine small active factor VIII fragment following transfusion in hemophilic dogs.
    Allain JP; Cooper HA; Wagner RH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607-8. PubMed ID: 1198531
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibitors to monoclonal antibody purified factor VIII.
    Bell BA; Kurczynski EM; Bergman G
    Lancet; 1990 Sep; 336(8715):638. PubMed ID: 1975416
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intensive substitution therapy of hemophilics].
    Weissbach G; Domula M; Lenk H
    Kinderarztl Prax; 1976 Aug; 44(8):360-7. PubMed ID: 966462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.